Maxilase

Alpha amylase, the active ingredient in Maxilase, is an enzyme presented as an oral formulation for digestive aid use. It assists the breakdown of dietary starches and is employed to support patients with impaired pancreatic enzyme production, especially in conditions such as chronic pancreatitis, cystic fibrosis, or after gastric surgery.

GNH USA supplies Maxilase as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to multiple regions.

Maxilase, containing alpha amylase, is used as a digestive aid to improve starch digestion in several clinical situations. - Pancreatic exocrine insufficiency: enhances starch breakdown, helping to alleviate malabsorption and steatorrhea. - Cystic fibrosis‑related pancreatic insufficiency: supports nutrient absorption by supplementing deficient amylase activity. - Post‑gastric surgery (e.g., gastrectomy, bariatric procedures): aids digestion of complex carbohydrates during recovery. - Functional dyspepsia with carbohydrate intolerance: reduces bloating and discomfort by facilitating starch hydrolysis.

Alpha amylase supplementation may be associated with several adverse reactions, ranging from mild gastrointestinal symptoms to rare hypersensitivity events. Common Side Effects: - Abdominal discomfort or cramping. - Flatulence or bloating. - Diarrhea or loose stools. - Nausea or mild vomiting. - Skin rash or itching at the site of contact. Serious or Rare Side Effects: - Anaphylactic reaction: sudden swelling, difficulty breathing, or shock. - Severe hypersensitivity: angioedema, urticaria, or bronchospasm.

When considering Maxilase, several precautionary measures should be observed to ensure safe use. - Assess pancreatic function: confirm enzyme deficiency before initiating therapy. - Monitor for allergic reactions: discontinue if rash, itching, or respiratory symptoms develop. - Use with caution in patients with known hypersensitivity to amylase or other enzyme preparations. - Pregnancy and lactation: safety has not been established; weigh potential benefits against unknown risks. - Concomitant medications: evaluate possible interactions that may affect drug absorption. - Store at room temperature: keep in the original container, protect from moisture and direct heat.

Alpha amylase may influence the absorption or efficacy of certain co‑administered medicines. Major Interactions (Avoid): - Tetracycline antibiotics: enzyme may degrade the antibiotic, reducing its effectiveness. - Fluoroquinolone antibiotics (e.g., ciprofloxacin): reduced absorption when taken simultaneously. Moderate Interactions (Monitor Closely): - Oral iron supplements: decreased iron uptake due to accelerated carbohydrate digestion. - Warfarin: monitor INR as changes in gut flora may alter vitamin K metabolism. - Metformin: observe blood glucose levels as enhanced carbohydrate breakdown may affect glycemic control.